These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36836033)

  • 1. Tardive Syndrome Is a Mysterious Phenomenon with Different Clinical Manifestations-Review.
    Badarny S; Nassar R; Badarny Y
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nosology of tardive syndromes.
    Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
    J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting the record straight: The nosology of tardive syndromes.
    Truong DD; Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():146-150. PubMed ID: 30528171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive syndromes.
    Savitt D; Jankovic J
    J Neurol Sci; 2018 Jun; 389():35-42. PubMed ID: 29506749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of tardive syndromes: clinical recognition and management.
    Bhidayasiri R; Boonyawairoj S
    Postgrad Med J; 2011 Feb; 87(1024):132-41. PubMed ID: 21131613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on tardive dyskinesia: from phenomenology to treatment.
    Waln O; Jankovic J
    Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 23858394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive Dystonia.
    Skidmore F; Reich SG
    Curr Treat Options Neurol; 2005 May; 7(3):231-236. PubMed ID: 15814076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive Dyskinesia Following Low-Dose Risperidone.
    Rokon AE; Alsomali FA; Alrasheed MA; Alharbi AD; Alhamadh MS; Alqahtani AM; Alhamidy FK; Alotaibi MR
    Cureus; 2022 Dec; 14(12):e32319. PubMed ID: 36628029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone-Induced Tardive Syndrome.
    Tripathi R; Reich SG; Scorr L; Guardiani E; Factor SA
    Mov Disord Clin Pract; 2019 Sep; 6(7):601-604. PubMed ID: 31538095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
    Musco S; Ruekert L; Myers J; Anderson D; Welling M; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(4):336-343. PubMed ID: 31205194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced tardive syndromes.
    Ortí-Pareja M; Jiménez-Jiménez FJ; Vázquez A; Catalán MJ; Zurdo M; Burguera JA; Martínez-Martín P; Molina JA;
    Parkinsonism Relat Disord; 1999 Apr; 5(1-2):59-65. PubMed ID: 18591121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive syndrome: An update and mini-review from the perspective of phenomenology.
    Chen CY; Chiang HL; Fuh JL
    J Chin Med Assoc; 2020 Dec; 83(12):1059-1065. PubMed ID: 32956105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced tardive motor syndromes.
    Havaki-Kontaxaki B; Komborozos A; Kontaxakis V
    Psychiatriki; 2007 Oct; 18(4):315-30. PubMed ID: 22466675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
    Bhidayasiri R; Jitkritsadakul O; Friedman JH; Fahn S
    J Neurol Sci; 2018 Jun; 389():67-75. PubMed ID: 29454493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia: treatment with aripiprazole.
    Kang NR; Kim MD
    Clin Psychopharmacol Neurosci; 2011 Apr; 9(1):1-8. PubMed ID: 23430384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
    Kulkarni SK; Naidu PS
    Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.